
ajp@psych.org
For verified host and producer emails, sign up to view.
Episodes: 232
Frequency: Monthly
Rating: 3.9/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: USA
YouTube: 20.1k subscribers
ajp@psych.org
For verified host and producer emails, sign up to view.
Dr. Ned Kalin - AJP Editor-in-Chief who provides contextual discussion of the journal issue after the author interviews.
Dr. Dilip Jeste - Social Determinants Of Health In Psychiatric Disorders; Loneliness As A Risk Factor; Biopsychosocial Research And Clinical Care; Exposome And Mechanistic Understanding
Dr. Alan Schatzberg - Low-dose Buprenorphine After Ketamine For Suicidal Ideation In Major Depressive Disorder; Trial Rationale, Findings, And Implications
Dr. Jason Tucciarone - Low-dose Buprenorphine After Ketamine For Suicidal Ideation In Major Depressive Disorder; Trial Rationale, Findings, And Implications
Dr. Mara Oquendo - Strategic Vision For The Future Of Dsm; Incorporating Feedback; Science-forward Framing; Documentation/coding Changes; Lived Experience
July 2026: Social Determinants of Health in Psychiatric Disorders: Exciting Opportunities for Biopsychosocial Research and Clinical Care
July 01, 2026
Dr. Dilip Jeste (Social Determinants of Health Network, La Jolla, CA) joins the podcast to discuss how social determinants of health interact with treatment for psychiatric disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin once again puts the rest of the July issue into context. 00:31 Impacts of social determinants of health on psychiatric disorders, research, and clinical care 04:43 Health related social needs versus social determinants of health 08:47 Loneliness as a...
June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
June 01, 2026
Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation. AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression. 01:20 Tucciarone and Schatz...
Special Episode: The Future of DSM
May 15, 2026
In this special episode of AJP Audio, AJP Editor-in-Chief Dr. Ned Kalin is joined by Dr. María Oquendo (Perelman School of Medicine at the University of Pennsylvania, Philadelphia), chair of APA's Future DSM Strategic Committee to discuss a series of commentaries published in the May issue of the Journal discussing the strategic vision for the future of DSM. 00:39 Oquendo interview 03:07 Size of the response 04:18 Feedback 06:04 Incorporating the feedback 07:57 Emphasizing sci...
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings